Segment Information - Segment Revenue, Operating income (loss) and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting Information [Line Items]
Revenue	$ 52,483	$ 24,854	$ 104,614	$ 73,963
Total operating income (loss)	21,412	(7,143)	7,600	(15,484)
Depreciation and amortization	2,151	2,206	6,365	6,902
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	52,483	24,854	104,614	73,963
Total operating income (loss)	24,643	(3,921)	16,933	(6,450)
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	46,014	17,528	84,739	52,889
Total operating income (loss)	21,777	(7,308)	7,483	(16,712)
Depreciation and amortization	1,997	2,020	5,883	6,347
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	6,469	7,326	19,875	21,074
Total operating income (loss)	2,866	3,387	9,450	10,262
Depreciation and amortization	78	88	230	260
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Total operating income (loss)	(3,231)	(3,222)	(9,333)	(9,034)
Depreciation and amortization	$ 76	$ 98	$ 252	$ 295